ZeroHarm Sciences
PrivateLast Round
Series A
Feb 25, 2026
Total Funding Raised
$7.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ZeroHarm Sciences is a nutraceutical company that develops plant-based health supplements using proprietary nano-formulation technology.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Biotechnology, Sports & Fitness, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZeroHarm Sciences Comparables
Compare ZeroHarm Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hindustan Unilever | 83% | |
| USV Private Limited | 81% | |
| Cymbiotika | 79% | |
ZeroHarm Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 25, 2026 |
ZeroHarm Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alkemi Growth Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
$7.15M round led by Kotak Lifesciences Fund I.
- Jan 2, 2026
Monthly visitors increased 110% MoM, reaching 95.3K.
ZeroHarm Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ZeroHarm Sciences's valuation, stock price, and market status.